Serum adiponectin and cortisol levels are not affected by studied ADIPOQ gene variants: Tehran lipid and glucose study.
ADIPOQ
Adiponectin
Cortisol
Obesity
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
18 Apr 2022
18 Apr 2022
Historique:
received:
11
01
2022
accepted:
11
04
2022
entrez:
19
4
2022
pubmed:
20
4
2022
medline:
21
4
2022
Statut:
epublish
Résumé
Obesity is a major public health concern in developed and even developing countries worldwide. Adiponectin is a protein secreted by adipose tissue that modulates many metabolic processes and plays a vital role in obesity. This study aimed to determine the association of four variants of the ADIPOQ gene with serum adiponectin, cortisol levels and obesity status. This case-control study was performed on 164 obese individuals compared by 156 control from the Tehran Lipid and Glucose Study (TLGS). Standard procedures obtained anthropometric measures and metabolic parameters. Cortisol and adiponectin levels were measured by ELISA method. rs1501299, rs266729, rs17300539, and rs17366743 on the ADIPOQ gene were genotyped using the PCR-RFLP. The correlation between adiponectin gene SNPs and obesity were calculated by Additive, dominant, and recessive genetic models. Pearson's or Spearman's found correlations between adiponectin levels and metabolic and anthropometric variables. Data were analyzed using SPSS software Version 20. Adiponectin and cortisol levels were significantly lower in obese subjects compared to the control group (p < 0.05). There was a significant negative correlation between serum adiponectin level and BMI, waist circumference (WC), waist-hip ratio, hip circumference (HC), Fasting blood sugar (FBS) Triglyceride (TG), Total cholesterol (TC), Systolic blood pressure (SBP), Diastolic blood pressure (DBP) (r = - 0.147, r = - 0.324, r = 0.371, r = - 0.179, r = - 0.299, r = - 0.277, r = - 0.041, r = - 0.134, and r = - 0.149, respectively). A positive correlation was found between adiponectin and high-density lipoprotein cholesterol (HDL-C) (r = 0.29), but no significant correlations were found between adiponectin and Low-density lipoprotein cholesterol(LDL-C) and cortisol. ADIPOQ variant rs1501299 was significantly associated with cortisol levels in subjects with BMI ≥ 25 (P-value =0.039). Adiponectin and cortisol levels were associated with obesity. No ADIPOQ gene variants and haplotypes were associated with cortisol, Adiponectin, and obesity.
Sections du résumé
BACKGROUND
BACKGROUND
Obesity is a major public health concern in developed and even developing countries worldwide. Adiponectin is a protein secreted by adipose tissue that modulates many metabolic processes and plays a vital role in obesity. This study aimed to determine the association of four variants of the ADIPOQ gene with serum adiponectin, cortisol levels and obesity status.
METHODS
METHODS
This case-control study was performed on 164 obese individuals compared by 156 control from the Tehran Lipid and Glucose Study (TLGS). Standard procedures obtained anthropometric measures and metabolic parameters. Cortisol and adiponectin levels were measured by ELISA method. rs1501299, rs266729, rs17300539, and rs17366743 on the ADIPOQ gene were genotyped using the PCR-RFLP. The correlation between adiponectin gene SNPs and obesity were calculated by Additive, dominant, and recessive genetic models. Pearson's or Spearman's found correlations between adiponectin levels and metabolic and anthropometric variables. Data were analyzed using SPSS software Version 20.
RESULTS
RESULTS
Adiponectin and cortisol levels were significantly lower in obese subjects compared to the control group (p < 0.05). There was a significant negative correlation between serum adiponectin level and BMI, waist circumference (WC), waist-hip ratio, hip circumference (HC), Fasting blood sugar (FBS) Triglyceride (TG), Total cholesterol (TC), Systolic blood pressure (SBP), Diastolic blood pressure (DBP) (r = - 0.147, r = - 0.324, r = 0.371, r = - 0.179, r = - 0.299, r = - 0.277, r = - 0.041, r = - 0.134, and r = - 0.149, respectively). A positive correlation was found between adiponectin and high-density lipoprotein cholesterol (HDL-C) (r = 0.29), but no significant correlations were found between adiponectin and Low-density lipoprotein cholesterol(LDL-C) and cortisol. ADIPOQ variant rs1501299 was significantly associated with cortisol levels in subjects with BMI ≥ 25 (P-value =0.039).
CONCLUSIONS
CONCLUSIONS
Adiponectin and cortisol levels were associated with obesity. No ADIPOQ gene variants and haplotypes were associated with cortisol, Adiponectin, and obesity.
Identifiants
pubmed: 35436947
doi: 10.1186/s12902-022-01020-8
pii: 10.1186/s12902-022-01020-8
pmc: PMC9016932
doi:
Substances chimiques
ADIPOQ protein, human
0
Adiponectin
0
Cholesterol, HDL
0
Glucose
IY9XDZ35W2
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104Informations de copyright
© 2022. The Author(s).
Références
Vet J. 2012 Mar;191(3):292-8
pubmed: 21592831
Child Obes. 2016 Aug;12(4):300-13
pubmed: 27159547
BMC Endocr Disord. 2021 Mar 9;21(1):45
pubmed: 33750349
Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):93-100
pubmed: 19481913
Diabetes. 2008 Dec;57(12):3353-9
pubmed: 18776141
Biomed Res Int. 2020 Jun 21;2020:6383906
pubmed: 32685510
Nutrients. 2019 Sep 12;11(9):
pubmed: 31547312
Eur J Endocrinol. 2009 Jan;160(1):39-43
pubmed: 19088327
Diabetes Res Clin Pract. 2017 May;127:254-264
pubmed: 28407551
J Adolesc Health. 2013 Jun;52(6):731-7
pubmed: 23402983
Mol Genet Metab Rep. 2020 Sep 12;25:100648
pubmed: 32983895
Obesity (Silver Spring). 2006 Sep;14(9):1498-504
pubmed: 17030959
Biomark Insights. 2009 Oct 13;4:123-33
pubmed: 20029651
Diabetol Metab Syndr. 2018 Jun 04;10:44
pubmed: 29991967
BMC Endocr Disord. 2019 Jun 3;19(1):55
pubmed: 31159801
J Funct Morphol Kinesiol. 2020 Jun 19;5(2):
pubmed: 33467260
Endocr Regul. 2018 Oct 1;52(4):176-184
pubmed: 31517610
Biochimie. 2012 Oct;94(10):2157-63
pubmed: 22449616
Mol Genet Metab Rep. 2017 May 30;12:44-50
pubmed: 28580300
Physiol Behav. 2012 Dec 5;107(5):809-13
pubmed: 22306535
Bol Med Hosp Infant Mex. 2015 Jan - Feb;72(1):26-33
pubmed: 29421176
Clin Pharmacol. 2010;2:105-10
pubmed: 22291493
Gene. 2013 Sep 25;527(2):663-9
pubmed: 23845780
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1206-e1220
pubmed: 33270115
Iran J Basic Med Sci. 2014 Aug;17(8):577-82
pubmed: 25422750
Iran Biomed J. 2016 Jul;20(3):152-60
pubmed: 26781170
J Diabetes Complications. 2009 Jul-Aug;23(4):265-72
pubmed: 18599322
BMC Public Health. 2013 Jan 30;13:88
pubmed: 23363707
J Med Biochem. 2021 Jan 26;40(1):33-40
pubmed: 33584138
Rev Assoc Med Bras (1992). 2015 Jan-Feb;61(1):72-80
pubmed: 25909213
Atherosclerosis. 2006 Oct;188(2):231-44
pubmed: 16581078
J Am Coll Cardiol. 2007 Feb 6;49(5):531-8
pubmed: 17276175
Gene. 2013 Jan 1;512(1):61-3
pubmed: 23041553
Appl Physiol Nutr Metab. 2018 May;43(5):445-452
pubmed: 29200312
J Cardiometab Syndr. 2009 Winter;4(1):44-9
pubmed: 19245516
Eur J Clin Nutr. 2010 Jan;64(1):105-7
pubmed: 19690575
Horm Behav. 2010 Nov;58(5):699-704
pubmed: 20483360
Diabetes Res Clin Pract. 2012 Aug;97(2):290-7
pubmed: 22497971
J Clin Endocrinol Metab. 2003 Jun;88(6):2838-43
pubmed: 12788897
Diabetes Res Clin Pract. 2011 Mar;91(3):e71-4
pubmed: 21208676
Gene. 2012 Mar 15;496(1):63-7
pubmed: 22269154
BMC Public Health. 2019 Oct 15;19(1):1293
pubmed: 31615464
Biomolecules. 2019 Sep 26;9(10):
pubmed: 31561637
PLoS One. 2018 Sep 28;13(9):e0204502
pubmed: 30265726
Arch Med Res. 2012 Feb;43(2):145-53
pubmed: 22374249
Diabetes Metab Syndr Obes. 2021 Feb 16;14:705-717
pubmed: 33623406